MARLEE BOOTY: Open Payments
NPI 1306445069 · MCCOMB, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,980 in 144 payments from 44 companies in 2025. Trend: 2023 $2,259 · 2024 $2,043 · 2025 $2,980
Food & beverage: $2,756Education: $224
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $378 |
| PFIZER INC. | 13 | $215 |
| AstraZeneca Pharmaceuticals LP | 8 | $199 |
| Merck Sharp & Dohme LLC | 8 | $180 |
| Incyte Corporation | 9 | $157 |
| Aveo Pharmaceuticals, Inc. | 4 | $140 |
| Celgene Corporation | 6 | $116 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $109 |
| ARRAY BIOPHARMA INC | 5 | $108 |
| Gilead Sciences, Inc. | 4 | $107 |
Products named: FOTIVDA, IBRANCE, ERLEADA, TALVEY, Trodelvy, KEYTRUDA, JAKAFI, TECVAYLI.
Industry payments across MS — which companies pay providers there.
